Oxford BioDynamics Plc (LON:OBD – Get Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as GBX 0.90 ($0.01) and last traded at GBX 0.98 ($0.01), with a volume of 2947997 shares trading hands. The stock had previously closed at GBX 1.06 ($0.01).
Oxford BioDynamics Price Performance
The firm has a market capitalization of £3.05 million, a PE ratio of -15.60 and a beta of 0.42. The business has a 50-day moving average of GBX 1.46 and a 200 day moving average of GBX 4.69. The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22.
Insider Activity at Oxford BioDynamics
In other Oxford BioDynamics news, insider David Holbrook bought 49,653 shares of the firm’s stock in a transaction dated Monday, October 28th. The stock was purchased at an average cost of GBX 1 ($0.01) per share, with a total value of £496.53 ($629.95). 16.78% of the stock is currently owned by insiders.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Read More
- Five stocks we like better than Oxford BioDynamics
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- What Are Dividends? Buy the Best Dividend Stocks
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Investing in Commodities: What Are They? How to Invest in Them
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
